Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1998-12-22
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 424479, 530324, 530395, 530399, A61K 3800, A61K 3824, A61K 950
Patent
active
058519920
ABSTRACT:
A pharmaceutical formulation comprising a growth hormone and asparagine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved preparation at ambient temperature. The formulation may be used to treat a patient with a disorder associated with growth hormone deficiency.
REFERENCES:
patent: 4816568 (1989-03-01), Hamilton, Jr. et al.
patent: 4917685 (1990-04-01), Viswanathan et al.
patent: 5547696 (1996-08-01), Sorensen
patent: 5552385 (1996-09-01), Christensen et al.
Johnson et al., The Journal of Biological Chemistry, vol. 264, No. 24, pp. 14262-14271, 1989.
Ottaway, Biochem. J., vol. 136 pp. 441-444, 1973.
Ottaway, Biochem. J., vol. 129, pp. 503-505, 1972.
Wang et al., J. Parent. Sci. & Tech., vol. 42, pp. S3-S26 (1988).
Manning et al., Pharmaceutical Research, vol. 6, No. 11, pp. 903-918 (1989).
Johnson et al., The Journal of Biological Chemistry, vol. 264, No. 24, pp. 14262-14271 (1989).
Teh et al., J. of Biol. Chem., vol. 262, No. 14, pp. 6572-6477 (1987).
Becker et al., Biotech. and App. Biochem., vol. 10, pp. 326-337 (1988).
Houghten et al., Arch. of Biochem. Biophysics, vol. 178, pp. 350-355 (1977).
Riggen et al., Analytical Biochem., vol. 167, pp. 199-209 (1987). 93-100 (1990).
Kaufman, Pharmaceutical Research, vol. 7. No. 3, pp. 289-292 (1990).
Becker et al., Biotech, and Applied Biochem., vol. 9, pp. 478-487 (1987).
Jensen et al., Biotech. and Bioengineering, vol. 36, No. 1, p. 1-11. 1990.
Mohamed Abdel A.
Novo Nordisk A S
Tsang Cecilia J.
LandOfFree
Treatment of growth hormone deficiency does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of growth hormone deficiency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of growth hormone deficiency will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047759